Cargando…
Patient Centricity in Patient Preference Studies: The Patient Perspective
Objectives: A factor contributing to the value of patient preference studies is patient centricity. This study aimed to explore how patients want to be involved in the design and conduct of patient preference studies. In addition, we investigated patients' expectations regarding the communicati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100374/ https://www.ncbi.nlm.nih.gov/pubmed/32266277 http://dx.doi.org/10.3389/fmed.2020.00093 |
_version_ | 1783511432720023552 |
---|---|
author | van Overbeeke, Eline Vanbinst, Inès Jimenez-Moreno, Aura Cecilia Huys, Isabelle |
author_facet | van Overbeeke, Eline Vanbinst, Inès Jimenez-Moreno, Aura Cecilia Huys, Isabelle |
author_sort | van Overbeeke, Eline |
collection | PubMed |
description | Objectives: A factor contributing to the value of patient preference studies is patient centricity. This study aimed to explore how patients want to be involved in the design and conduct of patient preference studies. In addition, we investigated patients' expectations regarding the communication of study results back to patients. Methods: Semi-structured interviews were conducted with patient representatives within three different disease areas: rheumatic diseases, cancer, and neuromuscular disorders. For each disease area, interviews were conducted with interviewees from Belgium, the Netherlands and the United Kingdom. Interviews followed a predefined interview guide covering topics relating to timing, level, and requirements for patient involvement in patient preference studies, as well as communication of results. Interviews were audio-recorded, transcribed and analyzed using framework analysis in NVivo 12. Results: A total of 14 interviews were conducted. Some interviewees believed that patients should be involved in all steps of a patient preference study. Patient involvement seemed most valuable during the design phase to support defining research questions and instrument design. During analysis, patients can be involved for optimal interpretation of results. Most interviewees mentioned that patient involvement should be on the level of advice or collaboration, not control. Interviewees expressed requirements for patient involvement relating to the knowledge of the involved patient, time investment, compensation and other incentives. Regarding communication of results, most interviewees wished to receive a brief and lay summary of the results, followed by a detailed explanation of both individual and average results accompanied by visuals. Conclusions: Patient involvement in patient preference studies could increase question comprehension by study participants and ensure correct interpretation of results by researchers. Patients want to be involved as advisors or collaborators, and considering their personal situation as well as establishing agreements on roles, time involvement and compensation early on will result in a most optimal partnership. |
format | Online Article Text |
id | pubmed-7100374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71003742020-04-07 Patient Centricity in Patient Preference Studies: The Patient Perspective van Overbeeke, Eline Vanbinst, Inès Jimenez-Moreno, Aura Cecilia Huys, Isabelle Front Med (Lausanne) Medicine Objectives: A factor contributing to the value of patient preference studies is patient centricity. This study aimed to explore how patients want to be involved in the design and conduct of patient preference studies. In addition, we investigated patients' expectations regarding the communication of study results back to patients. Methods: Semi-structured interviews were conducted with patient representatives within three different disease areas: rheumatic diseases, cancer, and neuromuscular disorders. For each disease area, interviews were conducted with interviewees from Belgium, the Netherlands and the United Kingdom. Interviews followed a predefined interview guide covering topics relating to timing, level, and requirements for patient involvement in patient preference studies, as well as communication of results. Interviews were audio-recorded, transcribed and analyzed using framework analysis in NVivo 12. Results: A total of 14 interviews were conducted. Some interviewees believed that patients should be involved in all steps of a patient preference study. Patient involvement seemed most valuable during the design phase to support defining research questions and instrument design. During analysis, patients can be involved for optimal interpretation of results. Most interviewees mentioned that patient involvement should be on the level of advice or collaboration, not control. Interviewees expressed requirements for patient involvement relating to the knowledge of the involved patient, time investment, compensation and other incentives. Regarding communication of results, most interviewees wished to receive a brief and lay summary of the results, followed by a detailed explanation of both individual and average results accompanied by visuals. Conclusions: Patient involvement in patient preference studies could increase question comprehension by study participants and ensure correct interpretation of results by researchers. Patients want to be involved as advisors or collaborators, and considering their personal situation as well as establishing agreements on roles, time involvement and compensation early on will result in a most optimal partnership. Frontiers Media S.A. 2020-03-20 /pmc/articles/PMC7100374/ /pubmed/32266277 http://dx.doi.org/10.3389/fmed.2020.00093 Text en Copyright © 2020 van Overbeeke, Vanbinst, Jimenez-Moreno and Huys. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine van Overbeeke, Eline Vanbinst, Inès Jimenez-Moreno, Aura Cecilia Huys, Isabelle Patient Centricity in Patient Preference Studies: The Patient Perspective |
title | Patient Centricity in Patient Preference Studies: The Patient Perspective |
title_full | Patient Centricity in Patient Preference Studies: The Patient Perspective |
title_fullStr | Patient Centricity in Patient Preference Studies: The Patient Perspective |
title_full_unstemmed | Patient Centricity in Patient Preference Studies: The Patient Perspective |
title_short | Patient Centricity in Patient Preference Studies: The Patient Perspective |
title_sort | patient centricity in patient preference studies: the patient perspective |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100374/ https://www.ncbi.nlm.nih.gov/pubmed/32266277 http://dx.doi.org/10.3389/fmed.2020.00093 |
work_keys_str_mv | AT vanoverbeekeeline patientcentricityinpatientpreferencestudiesthepatientperspective AT vanbinstines patientcentricityinpatientpreferencestudiesthepatientperspective AT jimenezmorenoauracecilia patientcentricityinpatientpreferencestudiesthepatientperspective AT huysisabelle patientcentricityinpatientpreferencestudiesthepatientperspective |